Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis

por Cork, Michael J., Thaçi, Diamant, Eichenfield, Lawrence F., Arkwright, Peter D., Chen, Zhen, Thomas, Ryan B., Kosloski, Matthew P., Dubost-Brama, Ariane, Prescilla, Randy, Bansal, Ashish, Levit, Noah A.
Publicado 2023